标普生物科技LOF(161127)
动态评分： 5.99分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | TGTX | TG Therapeutics Inc | 509.64 | 1.67% |
| 2024-12-31 | ADMA | ADMA Biologics Inc | 449.59 | 1.47% |
| 2024-12-31 | ROIV | Roivant Sciences Ltd | 430.7 | 1.41% |
| 2024-12-31 | IONS | Ionis Pharmaceuticals Inc | 423.9 | 1.39% |
| 2024-12-31 | CYTK | Cytokinetics Inc | 397.11 | 1.3% |
| 2024-12-31 | APLS | Apellis Pharmaceuticals Inc | 393.67 | 1.29% |
| 2024-12-31 | BPMC | Blueprint Medicines Corp | 396.12 | 1.29% |
| 2024-12-31 | RVMD | Revolution Medicines Inc | 386.11 | 1.26% |
| 2024-12-31 | EXEL | 伊克力西斯 | 360.38 | 1.18% |
| 2024-12-31 | BBIO | BridgeBio Pharma Inc | 350.81 | 1.15% |
| 2024-12-31 | CRSP | CRISPR Therapeutics AG | 333.44 | 1.09% |
| 2024-12-31 | ALKS | 阿尔凯默斯 | 307.94 | 1.01% |
| 2024-12-31 | SMMT | Summit Therapeutics Inc | 284.17 | 0.93% |
| 2024-12-31 | ACLX | Arcellx Inc | 278.34 | 0.91% |
| 2024-12-31 | RNA | Avidity Biosciences Inc | 262.95 | 0.86% |
| 2024-12-31 | BHVN | Biohaven Ltd | 258.1 | 0.84% |
| 2024-12-31 | NUVL | Nuvalent Inc-A | 237.07 | 0.77% |
| 2024-12-31 | SWTX | SpringWorks Therapeutics Inc | 226.94 | 0.74% |
| 2024-12-31 | TWST | Twist Bioscience Corp | 221.57 | 0.72% |
| 2024-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 217.74 | 0.71% |
公告&资料